ReThink Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

ReThink Pharmaceuticals General Information

Description

Owner and operator of a biotechnology company. The company works in the field of drug re-purposing by developing a distinct algorithm based on evolutionary genomics.

Contact Information

Website
www.rethinkpharmaceuticals.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Aluf Kalman Magen 3
  • Tel Aviv 6107075
  • Israel
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • Aluf Kalman Magen 3
  • Tel Aviv 6107075
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReThink Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 13-Jan-2021 000 Completed Out of Business
1. Accelerator/Incubator 24-Jun-2015 000 000 Completed Startup
To view ReThink Pharmaceuticals’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

ReThink Pharmaceuticals FAQs

  • When was ReThink Pharmaceuticals founded?

    ReThink Pharmaceuticals was founded in 2014.

  • Who is the founder of ReThink Pharmaceuticals?

    Guy Seemann, Ofer Tabach, Yuval Tabach, and Dmitry Shvartsman Ph.D are the founders of ReThink Pharmaceuticals.

  • Where is ReThink Pharmaceuticals headquartered?

    ReThink Pharmaceuticals is headquartered in Tel Aviv, Israel.

  • What industry is ReThink Pharmaceuticals in?

    ReThink Pharmaceuticals’s primary industry is Biotechnology.

  • Is ReThink Pharmaceuticals a private or public company?

    ReThink Pharmaceuticals is a Private company.

  • What is ReThink Pharmaceuticals’s current revenue?

    The current revenue for ReThink Pharmaceuticals is 000000.

  • How much funding has ReThink Pharmaceuticals raised over time?

    ReThink Pharmaceuticals has raised $5K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »